Program
* The program is subject to change.
* At the end of each presentation, we will ask everyone to vote for their evaluation and the results will be used to determine the Audience Award.
- 2:00pm(PST)
- Opening Remarks
- 2:05pm(PST)
- Session1 “Immunology and infectious diseases”
*sponsored by Kyoto University
- KinoPharma Inc.
Novel antiviral agent in clinical stage for HPV infection - CarbGeM Inc.
Combating antimicrobial resistance with AI - Rebirthel Co., Ltd.
Development of off-the-shelf T cell therapy for cancer and viral infection using the iPS cell technology - SUDx-Biotec Corporation
Chimeric Antigen Receptor expressed Natural Killer Cells for the treatment of Adult T-cell Leukemia (CAR-NK for ATL)
- 2:50pm(PST)
- Session 2 "Medical devices"
*sponsored by LINK-J
- Lilac pharma Inc.
Our microfluidic technology unlocks a future of individualized mRNA vaccine therapy
- R-NanoBio Co. Ltd.
Multiple analysis system at a clinic
- Triple W
DFree - Wearable device for urinary incontinence
- AquaTeX Medical
Aqua Embolic System: Novel Liquid Embolic System for Endovascular Surgery
- 3:35pm(PST)
- Session 3 "Small molecule therapeutics"
*sponsored by FBRI
- Takaha Pharmaceutical Co. Ltd.
Development of ATP enhancer [a combination drug of febuxostat
and inosine] effective for mitochondrial disease, Parkinson’s disease, and dementia
- BTB Drug Development Research Center
Non-addictive, non-opioid, post-NSAID painkiller
- NATiAS Inc.
Contributing to Global Healthcare through Innovation of Oligonucleotide Synthesis Technology
- Autoimmunity BioSolutions
Correcting Immunity with Targeted Therapies (MS, immuno-oncology)
- 4:20pm(PST)
- Session 4 "Regenerative medicine"
*sponsored by JETRO
- PuREC Co., Ltd.
Bone/Cartilage Regeneration by Uniquely Purified MSC, “REC”
- CUORiPS Inc.
Introduction of CUORiPS Inc.
- HiLung Inc.
Human Respiratory Cell Regeneration
- Oligogen, Inc.
Novel stem cell treatment for central nervous system disorders
- 5:05pm(PST)
- Award ceremony
- 5:20pm(PST)
- Closing remarks
- 5:25pm(PST)
- Adjourn